ERYMYCIN-20

ERYMYCIN-20 WSP

Active substance

Each gram contains:
Erythromycin (as thiocyanate)         200 mg

3 PHARMACEUTICAL FORM

Powder for suspension

4.2 Indications

ERYMYCIN-20 WSP is indicated for the treatment of chronic respiratory disease (CRD) caused   by Mycoplasma infections, and for the treatment of infectious diseases due to erythromycin sensitive bacteria such as staphylococcus aureus (infectious arthritis), Haemophilus paragalinarum (eg. Infectious coryza) and Pasteurella multocida (Pasteurellosis, pneumonia) in poultry.

4.3 Contraindications

Hypersensitivity to erythromycin

Concurrent administration of tetracyclines, Chloramphenicol, macrolides and Lincosamides.

4.4 Special warnings for each target species

None reported

4.9 Amounts to be administered and administration route

For oral administration.

100 g per 100 liter drinking water for 3-5 days.